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A B S T R A C T   
The aquatic environment becomes increasingly contaminated by anthropogenic pollutants such as pharmaceu-
tical residues. Due to poor biodegradation and continuous discharge of persistent compounds in sewage water 
samples, pharmaceutical residues might end up in surface waters when not removed. To minimize this pollution, 
onsite wastewater treatment techniques might complement conventional waste water treatment plants (WWTPs). 
Advanced oxidation processes are useful techniques, since reactive oxygen species (ROS) are used for the 
degradation of unwanted medicine residues. In this paper we have studied the advanced oxidation in a controlled 
laboratory setting using thermal plasma and UV/H2O2 treatment. Five different matrices, Milli-Q water, tap 
water, synthetic urine, diluted urine and synthetic sewage water were spiked with 14 pharmaceuticals with a 
concentration of 5 μg/L. All compounds were reduced or completely decomposed by both 150 W thermal plasma 
and UV/H2O2 treatment. Additionally, also hospital sewage water was tested. First the concentrations of 10 
pharmaceutical residues were determined by liquid chromatography mass spectrometry (LC-MS/MS). The 
pharmaceutical concentration ranged from 0.08 up to 2400 μg/L. With the application of 150 W thermal plasma 
or UV/H2O2, it was found that overall pharmaceutical degradation in hospital sewage water were nearly 
equivalent to the results obtained in the synthetic sewage water. However, based on the chemical abatement 
kinetics it was demonstrated that the degree of degradation decreases with increasing matrix complexity. Since 
reactive oxygen and nitrogen species (RONS) are continuously produced, thermal plasma treatment has the 
advantage over UV/H2O2 treatment.   
1. Introduction 
Aquatic ecosystems are increasingly polluted with anthropogenic 
compounds such as industrial waste, personal care products, micro-
plastics, pesticides and pharmaceutical residues. Pharmaceutical pollu-
tion has received more attention in recent years, due to their effect on 
the aquatic ecosystem and potential risk for the drinking water quality 
(Peake et al., 2016; Petrie et al., 2016; Banaschik et al., 2018). Improper 
disposal, runoff from manure and the continuous excretion from users 
cause the introduction of pharmaceuticals into the hydrosphere 
(Magureanu et al., 2015; Souza and Feris 2016; Li et al., 2019). Com-
plete or partially metabolized pharmaceuticals are discharged via do-
mestic and hospital effluents. These effluents are often complex 
chemical mixtures where pharmaceuticals and metabolites mix with 
other wastewater ingredients such as soap or other detergents (Beier 
et al., 2010; Ferrando-Climent et al., 2014; Peake et al., 2016; Ajo et al., 
2018). Excreted pharmaceuticals may be metabolized to more bioactive 
compounds than the administered parent drug. Conventional waste-
water treatment plants (WWTPs) cannot completely remove all phar-
maceutical residues. Due to continuous discharge and various 
wastewater treatment technologies, the degradation efficiency for each 
individual compound will differ from region to region (Peake et al., 
2016). Certain WWTPs do convert glucuronide metabolites back into 
their pristine structure by enzymatic processes (Ajo et al., 2018; Li et al., 
2019). Antiepileptics, contrast agents, analgesics, antibiotics and cyto-
static drugs are pharmaceutical classes often identified in raw hospital 
effluents (Beier et al., 2010; Ferrando-Climent et al., 2014; Ajo et al., 
2018). To complement and ease conventional WWTPs, onsite 
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wastewater treatment techniques are proposed (Gerrity et al., 2010; 
Banaschik et al., 2015; Ajo et al., 2018). Different techniques such as 
coagulation-flocculation (Suarez et al., 2009), reverse osmosis (Beier 
et al., 2010) or advanced oxidation processes (AOPs) (Kohler et al., 
2012; Ajo et al., 2018) are studied on pilot-scale to treat hospital 
wastewater. However, further development of a fully operational on-site 
treatment technique is often economically too expensive for hospitals to 
realize (Banaschik et al., 2015; Ajo et al., 2018). AOPs covers the prin-
ciples of using ROS for the degradation of contaminants by ozone, 
hydrogen peroxide, peroxone (O3/H2O2) Fenton reaction (Fe2+/H2O2), 
UV, photocatalytic, supercritical and non-thermal gas discharges based 
oxidative degradation technology (Banaschik et al., 2015; Magureanu 
et al., 2015; Marković et al., 2015). According to Ajo et al., (2018), 
plasma treatment is the most efficient technique to produce ROS. In 
previous studies high degradation efficiencies were observed for phar-
maceuticals treated with non-thermal plasma (Banaschik et al., 2018) or 
the combination of non-thermal plasma with iron as a catalyst 
(Marković et al., 2015). Plasma-driven activation of water is a new AOP 
that uses a hot arc (thermal plasma) in air over water to increase both 
reactive oxygen and nitrogen species (RONS) in water (Hoeben et al., 
2019; Graumans et al., 2020). In a previous optimization 
laboratory-scale experiment we demonstrated that a thermal arc dis-
charged in air over water is capable of the degradation of cyclophos-
phamide in tap water (Graumans et al., 2020). The aim of the present 
study was to determine the applicability of thermal plasma to complex 
matrices. Pharmaceuticals were added to different aquatic matrices, see 
Fig. 1. Subsequently a generic extraction technique was developed to 
determine 14 selected compounds. This method was used to analyze 
Fig. 1. The 14 selected pharmaceutical compounds, including their classifications and physicochemical properties.  
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pharmaceutical residues in synthetic and real wastewater matrices such 
as hospital and domestic sewage water. After analytical determination 
and characterization of the pharmaceutical residues the hospital effluent 
was also plasma-treated, to determine the efficacy on real wastewater 
samples. Due to the wide variety in physicochemical properties of the 
selected pharmaceuticals, in addition to solid phase extraction, a novel 
liquid-liquid extraction method for the polar component metformin was 
developed. 
2. Materials and methods 
2.1. Chemicals and reagents 
Pharmaceutical standards, iopamidol (IOP), diatrizoic acid (DIA), 
fluoxetine (FLU), diclofenac (DF), metoprolol (MET), carbamazepine 
(CB), terbutaline (TER), phenazone (PHE), acetaminophen (APAP), 
ciprofloxacin (CIP), doxycycline (DOX) and metformin (MF), all with 
>98% purity were retrieved from either Sigma Aldrich/Fluka Analytical 
(Zwijndrecht, the Netherlands) or Merck Group (Darmstadt, Germany). 
Endoxan and Iomeron were obtained from Baxter (Utrecht, the 
Netherlands) and Bracco (Konstanz, Germany) respectively used to 
prepare a stock solution for cyclophosphamide (CP) and iomeprol 
(IOM). Mobile phase and buffer solutions were freshly prepared in ul-
trapure water using a Milli-Q Academic A10 system with a resistivity of 
18 MΩ cm (Millipore, Amsterdam the Netherlands). Pharmaceutical 
stock solutions, with a concentration of 1.0 mg/mL were prepared in 
50:50 (v/v) methanol water. Single aliquots of 10.0 μg/mL were sub-
sequently prepared in Milli-Q water and further diluted together to have 
a pharmaceutical mixture (n = 14) with a concentration of 100.0 μg/L. 
Prior to analysis and solid phase extraction calibration standards were 
freshly prepared, ranging from 0.5 up to 100.0 μg/L (n = 6). Deuterated 
internal standards (dIS) were all obtained from Toronto Research 
Chemicals (North York, Canada) and prepared as single stock solutions 
(1.0 mg/mL) in methanol (SI paragraph S4). Compounds needed for the 
preparation of buffers and simulation matrices included NH4HCO2, 
NaCl, Na2SO4, KCl, KH2PO4, CaCl2 ⋅ 2H2O, NH4Cl, K2HPO4, MgSO4, 
sodium dodecyl sulfate, creatine, urea, peptone and meat extract. These 
chemicals were either acquired from Sigma Aldrich/Fluka Analytical 
(Zwijndrecht, the Netherlands) or Merck Group (Darmstadt, Germany). 
UPLC-MS analytical grade chemicals formic acid (FA), methanol 
(MeOH) and acetonitrile (ACN) were purchased at Merck Group 
(Darmstadt, Germany) and Boom B.V. (Meppel, the Netherlands) 
respectively. 
2.2. Advanced oxidation processes 
2.2.1. Plasma-driven water activation 
Thermal plasma discharge was performed using a laboratory-scale 
plasma activation unit from VitalFluid (Veldhoven, the Netherlands), 
comprising a 150 W, 1 MHz dual resonant power modulator with 8 kV 
arc operation voltage, creating a hot arc in air over water (Pemen et al., 
2017; Hoeben et al., 2019). A thermal electric discharge with voltages 
up to 40 kV was generated in air over water. Thermal arc operation was 
performed in ambient air with a power output of 150 Watt (W). To 
maintain the temperature of the water during activation between 20 and 
35 ◦C, the plasma unit was equipped with an active Peltier cooler. 
2.2.2. UV-C/H2O2 
Stationary UV-C irradiation was performed by using a modified 
Aetaire UV air disinfection unit. To irradiate UV-C (Philips PL-L 60 W/4 
P HO UV-C lamp, Ekkersrijt, the Netherlands) at 253.7 nm, an opening 
of 28 cm × 7 cm was used. The distance between the lamp and aqueous 
matrix surface was approximately 20 cm. At the start of the advanced 
oxidation process, 0.22 mM (~10 mg/L) hydrogen peroxide (H2O2) 
from J.T. Baker, Avantor Performance Materials (Deventer, the 
Netherlands) was added. To minimize UV scattering and reflection, a 
container with an appropriate aperture (12 cm, wide) was placed over 
the glass beaker. The UV-C irradiance at the aqueous matrix surface was 
extended and derived from our previous oxidation study (Graumans 
et al., 2020), (SI paragraph S1). 
2.3. Simulated aqueous matrices 
Thermal plasma and UV-C/H2O2 oxidation was applied in Milli-Q, 
tap water, synthetic urine, diluted urine and synthetic sewage water 
matrix. All tested aqueous solutions were freshly prepared at the start of 
the experiment. Milli-Q water was individually tested but also used for 
the preparation of synthetic urine and synthetic sewage water. A healthy 
male volunteer consented to provide urine. This urine was diluted to a 
20% v/v ratio, in Milli-Q water, to simulate sewer dilution of flushed 
urine. Physicochemical characteristics of the tap water matrix were 
adopted from the freely available January–December 2019 quality 
standard report (Vitens, Arnhem). An average pH of 7.73 was reported, 
with a total organic carbon (TOC) concentration of <0.5 mg/L and 
turbidity of 0.24 NTU, detailed information is given in the supplemental 
data (Table S3). To standardize the advanced oxidation processes, both 
techniques were used in 500 mL aqueous matrix and during treatment 
magnetically stirred. The initial pharmaceutical concentration (n = 14) 
was 5 μg/L. The oxidative pharmaceutical degradation was determined 
by collecting samples at time intervals of 5, 10, 15, 30, 45, 60, 90 and 
120 min. Prior to and after oxidative treatment the temperature and pH 
were measured. Direct LC-MS/MS injection was applied on the matrices, 
Milli-Q water, tap water and synthetic urine. Sample pre-treatment was 
applied on diluted urine, synthetic sewage water and actual wastewater 
samples prior to LC-MS/MS analysis. Centrifugal filtration was used for 
the urine samples, where solid phase extraction and liquid-liquid 
extraction were used to pretreat wastewater matrixes. 
2.3.1. Synthetic urine 
For the preparation of synthetic urine, all needed analytes were 
dissolved separately in 100 mL Milli-Q, to minimize the formation of 
precipitation or undissolved constituents. The final product comprises; 
25.0 g urea, 2.9 g NaCl, 2.3 g Na2SO4, 1.6 g KCl, 1.4 g KH2PO4, 1.1 g 
CaCl2 ⋅ 2H2O, 1.1 g creatinine and 1.0 g NH4Cl in 1000 mL Milli-Q, 
simulating human urine composition (Giannakis et al., 2018). 
2.3.2. Synthetic sewage 
To simulate the composition of sewage water, a standardized pro-
tocol from the Organization for Economic Co-operation and Develop-
ment (OECD) was used. Similar to the preparation of artificial urine, all 
analytes were prepared separately in 100 mL of Milli-Q. The final syn-
thetic sewage water solution contained; 160.0 mg Peptone, 110.0 mg 
Meat Extract, 30.0 mg Urea, 28.0 mg K2HPO4, 7.0 mg NaCl, 3.0 mg 
CaCl2 ⋅ 2H2O and 0.5 mg MgSO4 in 1000 mL Milli-Q water (OECD, 
2001). 
2.4. Sewage water sample collection 
End-of-pipe hospital sewage water (HSW) samples were periodically 
collected for one week in September 2019 (composite sample). The HSW 
samples were collected in two separate jerry cans to obtain a sample 
including the weekend (Thursday – Monday 12–Sep 16, 2019) compared 
to working days sample (Monday – Thursday 16–Sep 19, 2019). In 
addition to compare the pharmaceutical concentration present in HSW, 
also domestic sewage water (DSW) was sampled on Oct 31, 2019 (as a 
grab sample). These samples were taken from a residential area with no 
supply of HSW. Upon arrival in the laboratory the wastewater samples 
were directly centrifuged and vacuum-filtered using a Whatman Filter 
grade 1 (Maidstone, United Kingdom). The filtered wastewater samples 
were distributed in separate clean plastic aliquots, labelled and stored in 
the fridge (4 ◦C) or freezer (− 20 ◦C). Samples stored in the fridge were 
analyzed within 72 h to maintain the approximate pharmaceutical shelf 
M.H.F. Graumans et al.                                                                                                                                                                                                                       
Environmental Research 195 (2021) 110884
4
life. 
2.5. Centrifugal filtration 
To analyze the pharmaceutical oxidative degradation in diluted 
urine matrix, 0.5 mL urine sample was placed into a Spin-X centrifugal 
tube from Costar (Salt Lake City, USA). This Spin-X tube is equipped 
with a 0.22 μm cellulose acetate filter and placed on top of a 2.0 mL tube. 
To filter the urine sample, an Eppendorf MiniSpin (Nijmegen, the 
Netherlands) centrifuge is used for 5 min at maximum speed (134000 
rpm). After spinning, a clear urine sample was transferred to a LC-MS/ 
MS vial for analysis. 
2.6. Solid phase extraction 
Acidic buffer solution (ABS) was prepared by dissolving 10 mM of 
ammonium formate (NH4HCO2, ≥99% HPLC grade salt) and 3.25 mL of 
formic acid (FA, 98–100%) in Milli-Q to obtain a pH of ~2.2. Oasis HLB 
3 cc (cm3) solid phase extraction (SPE) cartridges with 60 mg of solid 
sorbent from Waters Corporation (Milford, USA), were selected for the 
extraction. SPE cartridges were conditioned with 2.0 mL of methanol 
and 2.0 mL of ABS. Prior to analysis, either 1.0 mL of analyte mixture, 
including 100 μL dIS, HSW or DSW was diluted in 4 mL of ABS. Vacuum 
extraction was performed using an SPE manifold from Analytichem in-
ternational (Bay Meadows Ln, USA). An aliquot of 5.0 mL aqueous 
pharmaceutical matrix was loaded on the SPE cartridge and subse-
quently washed with 1.0 mL ABS to remove impurities. After sample 
loading, the retained pharmaceuticals were extracted using 5.0 mL of 
methanol. Next, the extracts were vaporized under a gentle stream of 
nitrogen using a sample concentrator (Stuart, Stone, United Kingdom). 
at 40 ◦C. The vaporized samples were reconstituted in mobile phase A 
(0.1% formic acid) prior to LC-MS/MS analysis. To develop an extrac-
tion method for pharmaceuticals in a complex matrix in a broad con-
centration range, the recovery of the selected pharmaceuticals was 
determined in Milli-Q and synthetic sewage water by using three 
controlled concentrations, 1.0, 10.0 and 50.0 μg/L. 
2.7. Liquid-liquid extraction of metformin 
Due to the high hydrophilicity of metformin, no satisfactory recovery 
was obtained with SPE. To improve the recovery for metformin, a liquid- 
liquid extraction with acetonitrile at subzero temperatures was per-
formed according to a previously described method (Yoshida and Akane 
1999). An aliquot of 0.5 mL of a solution with a known metformin 
concentration was extracted by adding 0.1 mL of 2.0 mM sodium 
dodecyl sulfate (SDS) including 0.5 mL of acetonitrile. Sample aliquots 
were vortexed and centrifuged at maximum speed for 5 min. By placing 
the tubes for 30 min. at − 20 ◦C, the aqueous phase was separated from 
the acetonitrile phase. Compounds with affinity for the organic layer 
were retrieved from the acetonitrile phase. The acetonitrile layer was 
directly transferred to an LC-MS/MS vial for analysis. For the extraction 
from actual sewage water, the dimensions were increased by a tenfold, 
using the ratio 5:1:5 mL (Sewage Water: SDS: Acetonitrile). 
2.8. Liquid chromatography tandem mass spectrometry analysis 
An Acquity UPLC system from Waters Corporation (Milford, USA) 
was used for the analytical separation of pharmaceuticals and deuter-
ated internal standards. The LC system was online coupled to a Xevo TQ- 
S micro quadrupole mass spectrometer, with electro spray ionization 
(ESI), operated in positive ion mode for all selected compounds. Nitro-
gen gas was applied at 50 L/h in the cone and at 1100 L/h for des-
olvation. The desolvation temperature was set at 600 ◦C, and argon was 
used as collision gas during MS/MS. The voltages selected for the 
capillary and cone were 2 kV and 20 V, respectively. Multiple reaction 
monitoring (MRM) transitions for all pharmaceuticals were determined 
by direct infusion to the MS/MS. These transitions are presented as a 
precursor ion [M+H]+ combined with the corresponding fragmented 
daughter ion. The compounds were all individually infused via the flu-
idics interface by using a flow rate of 10 μL/min. The optimized results 
are given in Table S4 (SI paragraph S4). 
The LC unit consists of a solvent degasser, quaternary solvent man-
ager, seal wash pump, column oven and auto-sampler. Gradient LC 
conditions were applied at a flow of 0.5 mL/min, using 2.5 μL of in-
jection volume and a column oven temperature set at 40 ◦C. Eluent (A) 
consisted of 0.1% v/v formic acid (FA, 98–100%) in Milli-Q water in 
combination with eluent (B) 100% v/v acetonitrile (ACN, UHPLC-MS). 
An Acquity UPLC BEH C18 (2.1 mm × 100 mm, 1.7 μm) reversed 
phase column was used for the chromatographic separation. The LC 
gradient program was started with 100% eluent A until 0.20 min, and 
quickly changed to 100% B within 2.0 min. This 100% B was maintained 
until 4.3 min and subsequently ramped to 100% A at 4.5 min. The 
gradient program was stopped at 8 min. 
2.9. Data analysis 
For all pharmaceutical compounds the method selectivity was ob-
tained by using two MRM transitions per analyte. For each deuterated 
internal standard only one MRM transition was selected. Linear curve 
fitting (y = ax + b) was applied using TargetLynx LC-MS/MS data 
acquisition software (Waters Corporation Milford, USA). Data quantifi-
cation for metformin (MF) was done by using a quadratic curve fitting (y 
= ax2 + bx + c). To minimize the y-value error of the low analyte 
concentrations, all calibration points were equally weighted by using a 
weighting factor 1/X (Almeida et al., 2002; Gu et al., 2014). The phar-
maceutical oxidative degradation kinetics were plotted using GraphPad 
Prism 5.03 statistical software (Graphpad Inc., CA, USA) and the con-
version level was determined using eq. (1) (Graumans et al., 2020). SPE 
recovery data was determined by dividing the extract concentration 
through the original concentration, see eq. (2). A two-sided t-test was 
applied to test for statistical significance of degradation over time, 
assuming first-order kinetics Eq. (3) (Miller and Miller 2010). 
R=(1 − Ct /C0)⋅100 % (1)   
R‾ = Conversion level (%) (n = 4) 
Ct = Concentration of the test substance at the end of treatment (μg/ 
L) 












√ (3)   
t = t-calculated 
r2 = Correlation coefficient of the log-normal transformed line 
3. Results and discussion 
3.1. Pharmaceutical degradation using thermal plasma activation 
The oxidative conversion levels of 14 analytes, spiked in five 
different matrices, were evaluated in a controlled setting. Selected 
pharmaceuticals at given initial concentrations were degraded by 
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oxidation to an energy density and compound dependent extent using 
150 W thermal plasma treatment, (Table 1). Milli-Q was used as ultra- 
pure water matrix where all molecules are solely oxidized by plasma- 
generated RONS. A time-based decomposition plot demonstrates that 
the chemical degradation kinetics are distinct for all analytes tested, see 
Fig. 2. DOX, DF, CP, PHE and APAP were all rapidly 100% decomposed, 
with similar abatement kinetics. The compounds CIP, FLU, CB and TER 
were converted for at least >90% within 120 min. The slowest degra-
dation was observed for MET (72.3%), IOM (66.9%), IOP (63.0%), DIA 
(41.3%) and MF (17.6%) after 120 min treatment. Although the chem-
ical degradation kinetics differ between compounds and matrices, dur-
ing thermal plasma treatment the analytes were observed to be 
subjected to exponential decay. Log-normal transformation of this con-
centration data resulted in linear time-based decomposition plots, see 
Fig. S5 (SI paragraph S5). The slope of this linear decay represents the 
first-order rate constant (k) where r2 > 0.50 demonstrates significant 
correlation for first-order degradation kinetics (SI paragraph S5). 
Comparison of the pharmaceutical degradation rate constants in 
Milli-Q with other matrices (Table 1 and Fig. S3 and 4 (SI paragraph 
S5)), it is demonstrated that the k value decreases with increasing matrix 
complexity. To demonstrate the influence of co-existing substances 
present in these treated matrices, the overall rate constant (k‾) was used 
to calculate the inhibition ratio, see eq. (4) (Tokumura et al., 2016). A 
ratio higher than 1.000 suggests inhibition by constituents and organic 
matter in the sample matrix indicating that the aqueous composition is 
of major influence on plasma oxidation efficiency. The matrix 
complexity and interference of co-existing substances was consecutively 
demonstrated to be:  
Table 1 
Pharmaceutical removal by thermal plasma treatment in different matrices  











































































































































































































































































































































a First-order reaction rate equation: -d[A]/dt. k, the first-order rate constant, is the slope of the line. Where [A] is the drug concentration and t(1/2) ¼ ln 2/k 
b No significant change due to moderate to low correlation coefficient in linear modelling of assumed first-order kinetics (r2 < 0.50). 
Fig. 2. The time-based decomposition plot for the pharmaceuticals IOM ( ), 
IOP ( ), DIA ( ), CIP( ), DOX ( ), FLU( ), DF ( ), MET ( ), CP( ), CB( ), 
TER ( ), PHE( ), APAP ( ) and MF( ), treated in Milli-Q water with 150 W 
thermal plasma. 
1.000(Milli− Q) < 1.344(Synthetic ​ Sewage) < 1.893(Tap ​ water) < 2.119(Synthetic ​ urine) < 5.000(Urine).
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It is demonstrated that the aqueous composition is of great influence 
on the plasma oxidation efficiency. Despite the overall inhibitory effect 
of co-existing substances in various tested media, synthetic sewage and 
tap water, compared to Milli-Q, showed improved degradation rate 
constants for DOX, CP, TER, PHE and MF. The relatively small 
improvement in degradation for these compounds is attributed to matrix 
conductivity. Enhanced conductivity will increase the ability of facili-
tating electrical current through an aqueous medium, suggesting that 
the pre-existence of ions in tap water and synthetic sewage accelerate 
the transfer of specific RONS (Brisset et al., 2011; Thirumdas et al., 
2018; Hoeben et al., 2019; Shimizu et al., 2020). Increased solution 
conductivity also increases the current of the thermal plasma arc, pro-
moting the chemical activity of the plasma discharge in the gas phase. A 
similar effect would have been expected in synthetic and diluted urine 
matrices, however, an inhibitory effect was observed. This effect is 
probably explained by the high concentration of the co-existing minerals 
and organic constituents present in g/L ranges compared to mg/L range 
in tap water and synthetic sewage water (OECD, 2001; Giannakis et al., 
2018). Shih and Locke (2011) demonstrated in their study an optimal 
conductivity of 150 μS/cm for the production of reactive species. 
Further increase of conductivity (up to 500 μS/cm) resulted in a decline 
of radicals and molecular species formed. Due to the presence of 
co-existing substances there is less direct contact with water molecules 
to produce hydroxyl radicals (R1). On the other hand minerals and 
organic constituents may cause quenching or the production of less 
reactive radicals (Shih and Locke 2011; Giannakis et al., 2018; Shimizu 
et al., 2020). Slower and no gradual abatement kinetics was therefore 
also observed in urine diltued with water, showing a poor correlation of 
r2 < 0.50 for the degradation of IOP (0.48 r2), DIA (0.02 r2) and MET 
(0.11 r2). 
3.2. Plasma oxidation chemistry 
Many factors can influence thermal plasma degradation efficiency. In 
our previous study we observed that electrical power input and initial 
analyte concentration were important parameters (Graumans et al., 
2020). Additionally, it was demonstrated that by continued activation of 
a relatively large volume of tap water (500 mL) and low pharmaceutical 
concentration (4 μg/L), a logistic oxidative degradation pattern for CP 
elapsed. Comparing the previously non-cooled plasma results with the 
current data, no logistic oxidative degradation pattern is found for CP 
and other treated analytes, see Fig. S6 (SI paragraph S6). This 
remarkable dissimilarity is attributed to the temperature of the plasma 
treated solution. Active cooling has a positive effect on the production of 
thermally labile species such as ozone, hydrogen peroxide and transient 
reactive nitrogen species, while high temperatures benefit nitric acid 
formation (Hoeben et al., 2019). Hydroxyl radicals (HO•) and their 
coupling product hydrogen peroxide (H2O2) are formed by 
plasma-water contact, either in the gas phase or at the plasma-water 
interface (R1) (Joshi and Thagard 2013). Two HO• radicals combine 
to form measurable hydrogen peroxide concentrations (R2) (Magureanu 
et al., 2018). On the other hand, in presence of organic molecules, such 
as pharmaceuticals HO• radicals will react by initiating oxidative 
degradation (Joshi and Thagard 2013; Magureanu et al., 2018). 
(R1)  
(R2) 
Pharmaceutical decomposition initiated by HO• radicals produced 
with immersed non-thermal pulsed corona plasma, was demonstrated 
before (Banaschik et al., 2018). Oxidative conversion levels for three 
identical compounds in Milli-Q were found for DIA (40%), DF (100%) 
and CB (75%) within 70 min. We observed decomposition levels of 
41.3%, 100% and 90.5% within 120 min for DIA, DF and CB, respec-
tively. Although the oxidative degradation of these pharmaceuticals 
shows similarities, it must be noted that the plasma degradation in our 
study is not solely based on hydroxyl radical interaction. With plasma 
discharge in ambient air and striking over water, also reactive nitrogen 
species are transferred in the liquid matrix (Hoeben et al., 2019; Grau-
mans et al., 2020), such as nitric oxide (NO), nitrogen dioxide (NO2), 
nitrous acid (HNO2), nitric acid (HNO3) and peroxynitrous acid 
(ONOOH). In addition to oxidative degradation, these RNS can also 
induce nitration and nitrosation reactions (Magureanu et al., 2018; 
Hoeben et al., 2019). Looking at the currently tabulated conversion 
levels (R‾) and corresponding half-lives (t1/2), (Table 1), it is clear that 
certain molecular structures are more suspectable to plasma produced 
RONS than others. Aromatic ring systems, unsaturated double bonds (C 
= C) and functional groups with electron donating properties have 
increased reactivity towards electrophilic oxidizing agents (HO• or NO2+) 
(Brown, 2007; Joshi and Thagard 2013; Banaschik et al., 2018; 
Magureanu et al., 2018). The reactivity of aromatic ring systems is 
however, not self-evident since an electrophile, such as a hydroxyl 
radical, is needed to interact (Brown, 2007). 
A technology such as plasma-induced water activation is used to 
generate electrophilic compounds, demonstrating that HO• radicals 
readily initiate an addition reaction by binding to an aromatic ring 
system, Fig. 3A. (Banaschik et al., 2018). A similar reaction pathway is 
expected during our thermal plasma treatment process, but are com-
plemented by nitration processes (Magureanu et al., 2018; Hoeben et al., 
2019; Graumans et al., 2020). With prolonged thermal plasma activa-
tion, the aqueous matrix pH is decreased by RONS (Table 2). Nitration 
reactions usually occur at acidic pH (<6), where a nitronium ion (NO2+) 
is substituted or added as an electrophile at the aromatic ring system 
(Squadrito and Pryor 1998; Brown, 2007). Chiron et al., (2010), iden-
tified 3-nitro-APAP as the nitration transformation product of APAP in 
WWTPs (Chiron et al., 2010), see Fig. 3B. Nitration reactions in WWTP 
are initiated by nitrifying bacteria who produce nitric oxide (NO•). NO•
is a precursor for nitrating agents such as peroxynitrite (ONOO− ). In 
acidic samples ONOOH is very unstable and will rapidly decompose into 
HO•, NO2 and HNO3 (Chiron et al., 2010; Jewell et al., 2014; Hoeben 
et al., 2019). Additionally, ONOO− can also react with CO2 yielding 
NO2• and CO3•- radicals (Chiron et al., 2010). For thermal plasma acti-
vation it is expected that similar RONS are produced (R3-6). However, it 
is expected that the combined attack of hydroxyl radical and molecular 
oxygen is the main degradation pathway in this thermal plasma study 
and that nitration oxidation will complement the oxidative process 
under favorable circumstances (Chiron et al., 2010; Jewell et al., 2014; 
Thirumdas et al., 2018; Magureanu et al., 2018; Hoeben et al., 2019). 
Fig. 3. During thermal plasma treatment distinct chemical processes will occur 
according to the produced RONS. Several RONS will initiate chemical processes 
on reactive molecular structures containing aromatic rings, unsaturated bonds 
or electron donating function groups. HO• radical attack is the favored degra-
dation pathway, reacting for example rapidly with the aromatic ring of DF by 
forming 4-hydroxy-DF (A). Additionally, nitration processes will also occur 
where for example NO2• radicals can add to aromatic ring of APAP by pro-
ducing 3-nitro-APAP (B). 
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Our previous study on degradation data of CP without active cooling 
indicated pharmaceutical dissolution after prolonged activation (Grau-
mans et al., 2019). This suggests that minimal HO• radicals were formed, 
but that molecular dissolution was catalyzed by acidic pH (<6) and 
increasing water temperature, both acting as stimulants for the nitration 





3.3. UV-C/H2O2 oxidative chemistry 
UV-C/H2O2 advanced oxidation process is another useful technique 
for the degradation of micropollutants such as pharmaceuticals (Wols 
et al., 2013). During the application with UV-C/H2O2 treatment, certain 
molecules are sensitive for both interactions and are rapidly converted 
by photolysis and hydroxyl radical attack (Wols et al., 2013). Hydrogen 
peroxide in the gas phase is rapidly dissociated by UV photons, pro-
ducing highly reactive hydroxyl radicals (•OH) that can interact with 
nearly all organic compounds (von Sonntag 2008; Zhao et al., 2014).•OH 
radicals will bind to C = C or C = N double bonds, initiate hydrogen (H) 
abstraction, or trigger electron transfer reactions (von Sonntag 2008; 
Banaschik et al., 2018). According to the degradation results (Fig. 4.), it 
is seen that UV-C/H2O2 attacks nearly all pristine molecular structures 
completely in Milli-Q water, Table 3. Pseudo first-order reaction kinetics 
ranged between 0.007 up to 0.591 min− 1, including corresponding 
half-lives (t1/2) between 0.4 and 99.0 min. In contrast to thermal plasma 
treatment, the complete conversion of IOM, IOP and DIA with 
UV-C/H2O2 is most remarkable, since the molecular reactivity of these 
molecules is relatively low (Bourin et al., 1997). DIA is weak acidic 
compound, where IOM and IOP are both nonionized over a wide pH 
range, see Table S5 (SI paragraph S7). 
The fully substituted aromatic ring with iodine atoms is character-
istic for contrast agents, since these structures facilitate X-ray absorption 
during clinical diagnosis (Bourin et al., 1997; Borowska et al., 2015). 
That these compounds are difficult to decompose during plasma 
oxidation is explained by the fully substituted aromatic ring, where the 
iodine functional groups hinder the availability of the unsaturated C- 
atoms (Rosati 1994; Bourin et al., 1997; Zhao et al., 2014; Banaschik 
et al., 2018). Assuming that hydroxyl radical attack is the major 
pathway during thermal plasma degradation study, it confirms that slow 
molecular invasion can occur (Banaschik et al., 2018). On the other 
hand it is noteworthy, that the hydroxyl radical can attack on the ipso 
positions of the aromatic ring, as observed with e.g. DIA, IOP and IOM 
(Jeong et al., 2010). Despite their slow chemical reactivity towards HO•
radicals, iodinated compounds are light sensitive Photolysis of these 
molecules causes deiodination (Eloy et al., 1991; Wols et al., 2013). 
Allard et al., (2016) demonstrated rapidly photolytically degraded IOP 
and DIA up to >90% within 2 min in deionized water by immersed UV 
irradiation at 254 nm (Allard et al., 2016). Although we use UV/H2O2 
treatment, similar fast complete conversion levels were found for IOM, 
IOP and DIA within 15 min, demonstrating that the used UV-C source 
(254 nm) is the most important technique for contrast agent degrada-
tion. In accordance with the study of Wols, we found that the majority of 
pharmaceuticals do not photolytically degrade at 254 nm UV irradia-
tion. Based on their data it was seen that DF, PHE and FLU can 
moderately decompose photolytically in Milli-Q, where MET, CP, CB, 
APAP and MF are scarcely sensitive to UV-C irradiation (Wols et al., 
2013). The poorest conversion levels were observed for APAP, CP and 
MF. Although UV-C/H2O2 treatment is an interplay between photo-
chemical degradation accompanied with HO• radicals, we found that 
UV-C irradiation has a large impact on the molecular degradation. 
3.4. Effect of complex matrices on UV-C/H2O2 treatment 
Also during UV-C/H2O2 oxidative treatment the matrix complexity 
has a significant effect on the oxidative degradation of molecules. Using 
again the inhibition factor (Eq. (4)), it has been observed that the 
coexisting substances in the aqueous matrix have even a greater influ-
ence on UV-C/H2O2 oxidation than during plasma treatment. The 
pharmaceutical degradation kinetics (Table 3) decrease when the matrix 
complexity increases: 
1.000(Milli− Q) : ​ 0.544(Tap ​ water) < 3.115(Synthetic Sewage) < 15.283(Synthetic urine)
< 54.00(Urine).
The rapid conversion levels in Milli-Q are presumably caused by the 
absence of minerals and organic impurities. Retardation of the chemical 
degradation kinetics in complex matrices like synthetic urine, diluted 
urine and synthetic sewage are attributed to minerals and the natural 
organic matter. Organic impurities, such as urea, meat extract and 
peptone will absorb UV light at the expense of a less effective photolytic 
process. Indirectly the production of HO• radicals is also diminished and 
minerals such as phosphate and chlorine will induce the production of 
less reactive secondary radicals (R7-8) (Borowska et al., 2015; Gian-
nakis et al., 2018). 
(R7)  
(R8) 
On the other hand, it was observed that the MF oxidation is increased 
in tap water. Chemical degradation kinetics are improved in tap water 
matrix (0.028 min− 1) compared to Milli-Q (0.007 min− 1), showing 
97.4% versus 52.9% degradation within 120 min, respectively. This 
effect is attributed to photoreactive NO3− (Lin et al., 2020), and in this 
study also improved degradation of MF was demonstrated in water 
Table 2 






























Fig. 4. UV-C/H2O2 oxidative degradation pattern in Milli-Q for the compounds 
IOM ( ), IOP ( ), DIA ( ), CIP( ), DOX ( ), FLU( ), DF ( ), MET ( ), CP( ), 
CB( ), TER ( 2), PHE( ), APAP ( ) and MF( ). 
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samples with amplified environmental factors, compared to pure water. 
Their experimental design was based on simulating environmental 
photolysis by using 6 h of UV-A irradiation at 40 cm distance. During 
this process, reactive oxygen species (ROS) are formed confirming that 
HO• radical attack is the favored MF degradation pathway (Lin et al., 
2020). Improved degradation results were found in the presence of high 
concentrations NO3− (0.60–0.62 mg/L) and to a lesser extent Cl− (up to 
<4 mg/L), which both promote the photo-reactivity by producing HO•
radicals (R9-R11) (Wang et al., 2017; Lin et al., 2020) As seen in the 
suggested chemical reactions, it is expected that primarily NO2 and NO3 
Table 3 
Pharmaceutical removal by UV-C/H2O2 treatment in different matrices.   









































































































































































































































































































































0.47 r2 * 
346.6 
*: No significant change due to moderate to low correlation coefficient in linear modelling of assumed first-order kinetics (r2 leg < 0.50). 
a No reaction rate could be determined, by the rapid interaction of the pharmaceutical with either H2O2 or UV-C irradiation. 
Fig. 5. SPE recovery percentages obtained in spiked synthetic sewage water (A). The extraction of known concentrations 1.0, 10.0 and 50.0 μg/L is compared to 
100%( 6) recovery for the compounds; IOM ( ), IOP ( ), DIA ( ), CIP( ), DOX ( ), FLU( ), DF ( ), MET ( ), CP( ), CB( 5), TER ( ), PHE( ), APAP ( ) and MF 
( ). Liquid-liquid extraction compared to SPE extraction (B). Recovery was determined for 50 μg/L MF( 9), without ( ) and with SDS ( ). 
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will play an improved role in UV-C/H2O2 tap water. As demonstrated in 
Table S3 (SI paragraph S3), it is seen that both Cl2 and NO3 are present 
in concentrations exceeded the threshold of <4.0 mg/L (Lin et al., 
2020). 
NO−3 →
UVNO− ∗3 (R9)  
(R10)  
(R11)  
3.5. Pharmaceutical extraction using solid phase extraction and liquid- 
liquid extraction 
A versatile SPE methodology was developed in synthetic sewage 
water for the detection of 14 different pharmaceuticals in raw hospital 
and residential wastewater samples. The extraction method was devel-
oped and optimized for synthetic sewage water to achieve an optimum 
recovery in a sterile matrix with comparable properties as raw waste-
water. Due to the wide range of physicochemical properties of our 
selected pharmaceuticals (n = 14), the current developed SPE and LLE 
methodology are a compromise to achieve the best overall extraction 
efficiency, see supporting information paragraph S8 for the detailed 
results. The currently developed SPE methodology has recovery per-
centages (S%) ranging from 27 up to > 100.0% for 13 pharmaceuticals 
in synthetic sewage water, see Fig. 5. 
The extraction of MF, was insufficient, since recovery percentages 
using Oasis HLB SPE cartridges were very low (S% >10.0). To minimize 
LC-MS/MS system contamination or have any recovery loss of other 
pharmaceuticals, an additional liquid-liquid extraction at subzero tem-
peratures from Yoshida et al. (1999) was modified especially for MF 
(Yoshida and Akane 1999). SDS was added to the sample to initiate a 
cation-anion interaction between MF and SDS. ACN was added to extract 
the SDS-MF complex from the aqueous matrix. As presented in Fig. 5B, it 
is seen that the LLE method can extract MF now with much better re-
covery, ranging from 64.9 up to ~100%. 
3.6. Pharmaceutical detection and mitigation 
The optimized SPE and LLE extraction methods were used on real 
wastewater samples taken from a hospital and residential area (Fig. 6). 
The concentrations (μg/L) of the 10 identified pharmaceuticals were 
comparable with other studies of Vieno et al. (2006); Yin et al. (2010), 
Petrie et al. (2016) and Ajo et al. (2018). Results reported for IOM and 
APAP are considered semi-quantitative because these values were 
extrapolated in a range beyond the highest standard concentration (100 
μg/L). Even with this limitation of our analytical method, nearly all 14 
selected pharmaceuticals were detected in the hospital effluent 
(Table 4). The presence of IOM, DIA and CP, illustrates the difference 
between hospital (HSW) and domestic sewage water (DSW), since 
contrast agents and certain anticancer drugs are hospital administered 
only pharmaceuticals. Absence of IOP, is clarified by the fact that IOM is 
the mainly used contrast agent for radiographic examinations at the 
Radboudumc. Despite the frequent usage of antibiotics, DOX has not 
been detected in HSW and DSW, due to its limited stability and affinity 
Fig. 6. Wastewater sampling points in the city of Nijmegen (the Netherlands). Sewage water was taken from a well at the Radboud University Medical Center (A) and 
in a residential area (B). The sewer system of the end of pipe hospital effluent has no connection to the domestic sewage water well. 
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for charged cations Ca2+ and Mg2+ (Soeborg et al., 2004; Loftsson 
2014). Tetracycline antibiotics, such as DOX, are stable under acidic 
conditions but undergo chemical reactions at neutral and basic pH, like 
epimerization where hydroxyl and hydrogen group substituents ex-
change within the molecule by forming iso- or anhydrotetracyclines 
(Loftsson 2014). Tetracyclines predominantly absorb to sediment par-
ticles making it difficult to determine detectable amounts in wastewater 
samples (Thornton, 2001). That TER and PHE have not been found in the 
sewage water samples might be attributed to fact that other pharma-
ceuticals are used with the same therapeutic effect. Alternatives for TER 
and PHE are salbutamol and propyphenazone, molecules with very 
similar chemical properties and therapeutic effects (Zuehlke et al., 
2007). Additionally, the route of discharge is also of importance, since 
concentrations of pharmaceuticals can vary per region. It is expected 
that the presence of TER is limited in urban sewage water samples, since 
the compound is mainly used as food additive in the veterinary sector to 
increase the amounts of lean meat of livestock (Zhou et al., 2017). The 
concentrations of pharmaceuticals detected in both HSW and DSW, 
provides qualitative information about their consumption. In the HSW it 
is worth mentioning the difference between the weekday and weekend 
sample, where the DSW sample reflects the continuous emission of 
prescription and over the counter medicines (Table 4). 
3.6.1. Oxidative degradation chemistry in hospital sewage water 
Previous pharmaceutical oxidative degradation results were ob-
tained in a controlled setting. To evaluate the efficiency of plasma- 
induced water activation and UV-C/H2O2 on untreated hospital 
effluent, pharmaceutical decomposition of the 10 identified compounds 
was determined, see Fig. 7. The overall conversion levels for IOM, DIA, 
CIP, FLU, DF, MET, CP, CB, APAP and MF are all near equivalent to the 
results obtained in the synthetic sewage water matrix. This is remark-
able since the determined concentrations for IOM (~2400 μg/L), DIA 
(~10 μg/L), CIP (~13 μg/L), APAP (~300 μg/L) and MF (~35 μg/L) 
were all much higher in HSW than in the spiked (5 μg/L) synthetic 
sewage water matrix, see Table S8 (SI paragraph S10). According to the 
controlled experimental results, it has become clear, that the efficiency 
of pharmaceutical degradation mainly depends on pH, matrix 
complexity and oxidative technique used. A high pharmaceutical con-
centration is also of influence, but primarily slows down the rate of 
chemical degradation (Graumans et al., 2019). That the high concen-
tration of IOM with UV-C/H2O2 treatment decreases so rapidly, is 
attributed to its sensitivity to UV irradiation. To demonstrate effective-
ness of both oxidative treatment techniques in hospital effluent, the total 
mass of the revealed pharmaceuticals was calculated according to a 
previously described method (Ajo et al., 2018). The overall conversion 
level was calculated with and without the contrast agents since the 
mass-based occurrence of IOM and DIA was relatively high compared to 
the other pharmaceuticals (Table 5). 
According to the results provided in Table 5 and S8 (SI paragraph 
S10), it is suggested that thermal plasma treatment has the advantage 
over UV/H2O2 treatment, since in addition to ROS, also RNS are 
continuously produced in plasma activated water. With the exception of 
IOM and DIA, thermal plasma oxidative degradation proves its effec-
tiveness in very complex matrices. The less gradual chemical degrada-
tion observed, during oxidative treatment in HSW is attributed to the 
matrix complexity. In our study only 10 compounds were detected in the 
HSW, but it is important to mention that many more analytes are to be 
expected (Ajo et al., 2018). Besides the pharmaceuticals that were not 
determined in this study, it is anticipated that molecules such as soaps, 
detergents, biotransformation products and hormones are also present 
in HSW. All these compounds will have an effect on the overall degra-
dation efficiency e.g. competitive inhibition. The observed increase in 
sample concentration overtime for the analytes CP and CB is caused by 
their metabolites. During oxidative treatment, their non-detected 
Table 4 
Pharmaceutical detection in hospital sewage water compared to domestic sewage water in the city of Nijmegen.  
Hospital sewage water (A) 
Thursday – Monday (12 - 16 Sep 2019, including a weekend) 
x‾ Concentration (μg/L) 
(±sd) n = 4 

















n.d. n.d. 0.43a 30.1 
(±13.6) 
Hospital sewage water (A) 
Monday – Thursday (16 - 19 Sep 2019, working days) 
x‾ Concentration (μg/L) 
(±sd) n = 4 















n.d. n.d. 82.1 (±81.9) 36.8 
(±14.9) 
Hospital sewage water (Pooled) 
x‾ Concentration (μg/L) 
(±sd) n = 2 

















n.d. n.d. 0.07a (±0.16) 19.0 
(±1.6) 
Domestic sewage water (B) 
Thursday (31 Oct 2019) 
x‾ Concentration (μg/L) 
(±sd) n = 4 
IOM IOP DIA DOX CIP FLU DF MET CP CB TER PHE APAP MF 
n.d. n.d. n.d. n.d. 1.1 
(±0.5) 
0.5 (±0.4) 5.6 
(±4.7) 




a It is recommended to analyse wastewater within 24h, to minimize biodegradation of APAP. 
b Determined concentrations exceeding the calibration range were quantified by linear extrapolation using the corresponding slope and intercept prepared in 
synthetic sewage water. 
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biological metabolites are reformed into the pristine structures. This will 
cause an increased peak value relative to the measured initial concen-
tration. Continuation of the oxidative treatment will cause further 
abatement and make it possible to degrade the compound completely 
(Aziz et al., 2018; Ajo et al., 2018; Graumans et al., 2020). 
3.7. Strengths and limitations of the study 
We developed an experimental set-up to provide insight into the 
degradation of 14 pharmaceuticals in complex matrices by use of AOP. 
The application of plasma treatment compared to UV-C/H2O2 on 
simulated matrices, indicates dependency of the degradation efficiency 
on matrix complexity and also varies with the method of oxidative 
treatment and the structural properties of the pharmaceuticals tested. 
The simulation matrices were compared with end-of-pipe hospital 
sewage water, sampled and processed by advanced oxidation. Due to 
matrix complexity and an unexpected broad concentration range in real 
life wastewater our analytical approach for synthetic sewage water 
showed some limitations for quantification of pharmaceuticals like IOM 
and APAP. Additionally, our lowest calibration point (0.5 μg/L) did not 
optimally serve quantification of FLU, DF, CP and CB, since their 
determined concentrations ranged between the LOD and lowest cali-
bration point in synthetic sewage water. Nonetheless, this laboratory 
study represents a useful first step in the experimental validation of 
plasma activation technology to complement onsite wastewater 
treatment. 
4. Conclusion 
With this study we have extensively studied the degradation of 
pharmaceuticals in multiple complex matrices using thermal plasma and 
UV/H2O2 oxidative treatment. Despite the matrix complexity has each 
Fig. 7. Thermal plasma oxidation (A) was applied on hospital sewage water (HSW, n = 3). 10 compounds were identified, showing the conversion levels for; IOM ( , 
32.5%), DIA ( , 23.8%), CIP( , 69.7%), FLU( , 11.8%), DF ( , 93.6%), MET ( , 43.3%), CP( , 100.0%), CB( , 36.4%), APAP ( , 100.0%), MF( , 77.7%). UV-C/ 
H2O2 oxidative degradation (B) demonstrated; IOM ( , 99.9%), DIA ( , 100.0%), CIP( , 98.6%), FLU( , 4.0%), DF ( , 100.0%), MET ( , 36.5%), CP( , 82.3%), CB 
( , N.C), APAP ( , 31.6%), MF( , 13.9%). For both techniques the pharmaceutical decomposition in HSW ( ) was compared to the controlled degradation results in 
synthetic sewage water ( ). It is illustrated that both plasma oxidation (C) and UV-C/H2O2 (D) oxidative treatment in HSW initiate equivalent abatement as in the 
simulated matrix. 
Table 5 
Total identified pharmaceutical concentration in hospital sewage water, demonstrating the effectiveness of plasma oxidation and UV/H2O2 treatment with and without 
contrast agents.  
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technique its own added value towards specific pharmaceutical classes. 
Single dose hydrogen peroxide in stationary UV-C/H2O2 treatment has a 
temporary effect, and involved photons cannot produce RNS, whereas 
ongoing plasma activation can produce both ROS and RNS continuously. 
The continuous production of reactive species makes plasma activation a 
useful technique for the application in complex matrices such as hospital 
effluent. The pharmaceutical degradation by temperature-controlled 
thermal plasma treatment is complemented by nitrification under 
acidic conditions. Further research using cell-based assays should reveal 
whether the toxicity of contaminated matrices is decreased. 
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